{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:43:33Z","timestamp":1787510613563,"version":"build-2736575974"},"reference-count":18,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,5,29]],"date-time":"2008-05-29T00:00:00Z","timestamp":1212019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatrics International"],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    The aim of the present paper was to investigate 20 pediatric patients with cerebral palsy and secondary osteoporosis and consider the efficacy, influence and index of treatment.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    A total of 10 boys and 10 girls, age 1\u201316\u2003years (mean 7.6\u2003years) with secondary osteoporosis and cerebral palsy treated for 6\u2003months, were studied. Bone mineral density (BMD) was measured. The bone turnover markers were measured just before and 4\u2003months after treatment or at the time of early discontinuation of treatment. The treatment was classified into two groups: vitamin D (alfacarcidol) only; and with bisphosphonate (risedronate).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Monotherapy with alfacarcidol was effective for secondary osteoporosis in children, but when used in combination with risedronate it was even more effective in improving BMD. In the two groups, bone\u2010specific alkaline phosphate (BAP) decreased from pretreatment to post\u2010treatment assessment in all but one case, but there was no significant correlation in the difference in \u0394BAP with \u0394BMD. \u0394BAP assumed changes in BAP in treatment either before or after, and \u0394BMD also assumed changes in BMD. N\u2010telopeptides of type I collagen (NTX)\/Cr decreased in all cases. The correlation of \u0394NTX\/Cr with \u0394BMD was not significant. The therapy and its efficacy did not correlate to the patients\u2019 age, sex, medicine regimen or enteral nutrition.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    Risedronate therapy is effective for patients presenting with secondary osteoporosis with cerebral palsy. Moreover, it is desirable to treat patients more aggressively from the early stage because risedronate is not affected by the patients\u2019 other factors.\n                  <\/jats:p>","DOI":"10.1111\/j.1442-200x.2008.02571.x","type":"journal-article","created":{"date-parts":[[2008,5,30]],"date-time":"2008-05-30T02:50:23Z","timestamp":1212115823000},"page":"269-275","source":"Crossref","is-referenced-by-count":36,"title":["Secondary osteoporosis in long\u2010term bedridden patients with cerebral palsy"],"prefix":"10.1111","volume":"50","author":[{"given":"Toshiyuki","family":"Iwasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Hosoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukifumi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,5,29]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s007740170001"},{"key":"e_1_2_5_3_2","first-page":"69","article-title":"Bone mineral density of the lumbar spine and total body mass in Japanese children and adolescents","volume":"103","author":"Nishiyama S","year":"1999","journal-title":"J. Jpn. Pediatr. Soc"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.6.1006"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.5.1846"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp038103"},{"key":"e_1_2_5_7_2","first-page":"1148","article-title":"A metaanalysis on the use of bisphosphonates in corticosteroid induced osteoporosis","volume":"26","author":"Homik JE","year":"1999","journal-title":"J. Rheumatol"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(99)70447-6"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2003.16.4.529"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2003.11.025"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-200X.2002.01561.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.59.5.781"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/000992289903800205"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2001.416800.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.4.990"},{"key":"e_1_2_5_17_2","first-page":"416","article-title":"Inhibitory effect of zonisamide on human carbonic anhydrase in vitro","volume":"43","author":"Masuda Y","year":"1993","journal-title":"Arzneimittelforschung\/Drug Res"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0387-7604(00)00118-2"},{"key":"e_1_2_5_19_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3165\/jjpn.18.27","article-title":"Three cases of urolithiasis during treatment with zonisamide","volume":"18","author":"Hayashi A","year":"2003","journal-title":"J. Jpn. Pediatr. Nephrol"}],"container-title":["Pediatrics International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1442-200X.2008.02571.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1442-200X.2008.02571.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T11:13:29Z","timestamp":1697282009000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1442-200X.2008.02571.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,29]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["10.1111\/j.1442-200X.2008.02571.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1442-200x.2008.02571.x","archive":["Portico"],"relation":{},"ISSN":["1328-8067","1442-200X"],"issn-type":[{"value":"1328-8067","type":"print"},{"value":"1442-200X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,29]]}}}